press

Between 20 and 22 April 2023, the world of Multiple Myeloma research will convene in Amsterdam, for three intense working days involving haematologists and clinical trials experts.
The event features 12 live sessions and the presentation of 73 abstracts. There will be four symposia, a sponsored lecture and five “Meet the experts” sessions. In addition, space will be dedicated to young researchers and to patient associations. Attendees will also have a chance to interact with speakers and moderators during lively debates and Q&A sessions.
The congress is promoted by the European EMN Network, headquartered in Rotterdam, and organized with the support of the Italian branch of the network, based in Turin.
Registration is via the site emn2023.com. Discounts apply for early registrations before 7 April.

Between 6 and 9 April, the world of Multiple Myeloma research will convene for a virtual meeting involving haematologists and clinical trial experts from Europe and beyond.
This virtual congress is promoted by the European EMN network, headquartered in Rotterdam, with the support of the Italian team in Turin, and in collaboration with the ER Congressi agency.
New therapeutic approaches aimed at increasing survival and quality of life of myeloma patients will be addressed. Sponsored sessions will provide a valuable overview of the new molecules and innovative therapeutic approaches.

The Congress, initially scheduled for 2020 and postponed due to the pandemic, will now be a digital event. It will take place between 3 and 6 March and will connect haematologists and clinical trial experts across the continent.
The first edition, held at Turin’s Lingotto Congress Centre in April 2018, registered some 700 participants from 44 different countries.
Uniquely during this second edition, delegates will have the opportunity to interface directly with the speakers through instant chats.
The digital Congress is promoted by EMN International. It’s organized with the support of EMN Research Italy, the Italian operating branch of the EMN network, in collaboration with the ER Congressi agency.

In Amsterdam (June 13th 2019), a symposium chaired by Prof. Mario Boccadoro, Hematologist at the University of Turin, member of the European Myeloma Network and President of the Executive Committee of the EMN Research Italy Working Group, will deal with a very topical issue: the relationship between the scientific community and pharmaceutical companies – a highly relevant topic in the era of personalized medicine.